Pinsent Masons advises on Epwin and Latium Merger

02 Feb 2012 | 10:58 am |

International law firm Pinsent Masons has advised Epwin (Holdings) Limited on its merger with Latium Group. The merger forms a new UK building products group with a turnover in excess of £275m.

Epwin is a leading building products provider in the UK with key brands in window material supply. The Epwin Group was founded in 1976 and has over 2,500 employees.

Jim Rawson, Founder and Chairman of Epwin, commented: "This is a major opportunity for the UK building products industry. In bringing together many of its leading businesses, in a British run, British owned group, we have the resource to invest in individual brands, product innovation and service, grow our business and most importantly, support our customers across sectors in doing the same."

 The Pinsent Masons team advising on the deal was led by Corporate Partner Paul Harkin and Senior Associate Zanna Patchett, assisted by Rhian Critchell and Christian Mulvihill. The banking team was led by Banking Senior Associate Esther Parkes and Associate Pippa Whitmore.

Commenting on the deal, Paul Harkin said: "We are delighted to have advised on the merger and wish the Group every success."

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts